Efficacy of green tea extract on ocular redness
Phase 2
Completed
- Conditions
- ocular surface irritation.Acute atopic conjunctivitis
- Registration Number
- IRCT138903234166N1
- Lead Sponsor
- Drug Applied Reaserch Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1.ocular redness 2.foriegn body sensation 3.eyestrain 4.ocular allergy. Exclusion criteria: 1.any intraocular inflammation 2.any corneal disease 3.viral or bacterial infections 4.any drug induced side effects
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forignn body sensation, redness, irritation, eye strain. Timepoint: 2 weeks. Method of measurement: clinical exam.
- Secondary Outcome Measures
Name Time Method Tear film stability. Timepoint: 2 weeks. Method of measurement: clinical exam.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-inflammatory effects of green tea extract in ocular surface inflammation?
How does EyeCalmin compare to standard-of-care treatments like antihistamines for acute atopic conjunctivitis?
Are there specific biomarkers that predict response to green tea extract in ocular surface irritation management?
What adverse events are associated with green tea extract formulations in ophthalmic use and how are they managed?
What are the potential synergies of EyeCalmin with other anti-inflammatory agents such as corticosteroids or mast cell stabilizers in treating ocular surface diseases?